The U.S. District Judge Robin L. Rosenberg indicated that Zantac lawsuits would continue to move forward via video conferencing, following the disruption caused by the nationwide COVID-19 pandemic.
According to a pretrial order issued by on April 3, Judge Rosenberg, recognizing the importance of keeping the litigation moving forward, scheduled an initial status conference and interviews for attorneys seeking leadership positions through video conferencing.
The Initial Conference, which was set for March 20, is now scheduled on May 12 at 09:00 AM. The interviews for the plaintiff’s leadership positions are scheduled on May 6 and May 7.
Zantac lawyers interested in appointments should submit written disclosure statements answering several questions listed in the pretrial order by 04:00 PM on April 16, via email and are not required to be notarized.
Currently, there are around 140 product liability lawsuits and class action cases filed throughout the federal court system, each alleging that the active ingredient in Zantac, ranitidine, produces high levels of the known human carcinogen N-Nitrosodimethylamine (NDMA).
